Evidence map›Paper›PMID 41310436›Full record

ArticleBMC bioinformatics2025

MOV&RSim: computational modelling of cancer-specific variants and sequencing reads characteristics for realistic tumoral sample simulation.

Francesca Longhin, Giacomo Baruzzo, Enidia Hazizaj, Diego Boscarino, Dino Paladin, Barbara Di Camillo

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesca LonghinDepartment of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padua, Veneto, Italy.ORCID http://orcid.org/0009-0007-2833-3543
Giacomo BaruzzoDepartment of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padua, Veneto, Italy. giacomo.baruzzo@unipd.it.ORCID http://orcid.org/0000-0001-6129-5007
Enidia HazizajAB ANALITICA, Srl, Via Svizzera 16, 35127, Padua, Veneto, Italy.ORCID http://orcid.org/0000-0001-8327-4530
Diego BoscarinoAB ANALITICA, Srl, Via Svizzera 16, 35127, Padua, Veneto, Italy.ORCID http://orcid.org/0009-0003-5774-1723
Dino PaladinAB ANALITICA, Srl, Via Svizzera 16, 35127, Padua, Veneto, Italy.ORCID http://orcid.org/0009-0004-2996-1195
Barbara Di CamilloDepartment of Information Engineering, University of Padova, Via Gradenigo 6b, 35131, Padua, Veneto, Italy. barbara.dicamillo@unipd.it.ORCID http://orcid.org/0000-0001-8415-4688

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBioinformatics pipelines for variant calling have undergone significant advancements due to the decreasing costs of next-generation sequencing. Accurate mutation detection is crucial for personalised medicine in cancer, particularly in assignment of therapy. Somatic variant calling, however, remains challenging due to diverse cancer types, heterogeneity, complex mutational profiles, and unpredictable sequencing errors. A dataset of fully characterised tumoral genomes and sequencing reads, large enough to represent the variability inherent in different cancer types, is still lacking, even considering synthetic data. The lack of such datasets hampers rigorous evaluation, benchmarking and optimization of variant callers for specific cancer types.

resultsThe contribution of this work is twofold. First, we conducted a comprehensive analysis of nine somatic sample simulators (Synggen, BAMSurgeon, SVEngine, VarSim, Xome-Blender, tHapMix, Pysim-sv, SCNVSim, HeteroGenesis) assessing their ability to control biological parameters, including variants characteristics (type, number, position, length, content, zygosity), and sample characteristics (clonality, contamination); and technical parameters, including reads characteristics (sequencing errors, coverage, base qualities). No single simulator provided complete control over both biological and technical parameters, nor guidance on tuning biological parameters for cancer-specific simulations. Consequently, we developed MOV&RSim, a novel simulator that leverages data-driven information to set variants and reads characteristics, producing realistic tumoral samples, and providing full control on biological and technical parameters. Additionally, we leveraged well-annotated variant databases to create cancer-specific presets that inform the simulator’s parameters for 21 cancer types.

conclusionThis new simulator, containerised with Docker and freely available for academic use, empowers users to define each biological parameter of a tumoral genome and faithfully replicates the variability of technical noise observed in real sequencing reads. The proposed simulator and presets represent the most adaptable and comprehensive framework currently available for generating tumor samples, enabling comprehensive benchmarking and, ultimately, the optimization of somatic variant callers across diverse cancer types.

Indexed as

Computational BiologyComputer SimulationGenetic VariationHigh-Throughput Nucleotide SequencingNeoplasmsSoftwareHumansMutationSequence Analysis, DNACancer-specific presetsGenetic variantsGold-standardReads characteristicsRealistic simulationSequencing readsSomatic sample simulatorTumoral clonalityTumoral heterogeneityVariants characteristics

Identifiers

PMID41310436
PMCPMC12659228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.